Cibc World Markets Corp Purchases 29,082 Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Cibc World Markets Corp increased its position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 47.0% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 90,992 shares of the real estate investment trust's stock after purchasing an additional 29,082 shares during the period. Cibc World Markets Corp's holdings in Sabra Health Care REIT were worth $1,576,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. JPMorgan Chase & Co. boosted its holdings in Sabra Health Care REIT by 222.4% in the third quarter. JPMorgan Chase & Co. now owns 9,886,917 shares of the real estate investment trust's stock worth $183,996,000 after purchasing an additional 6,819,919 shares during the period. Wellington Management Group LLP lifted its position in shares of Sabra Health Care REIT by 736.5% in the 3rd quarter. Wellington Management Group LLP now owns 2,396,835 shares of the real estate investment trust's stock worth $44,605,000 after buying an additional 2,110,307 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Sabra Health Care REIT by 324.3% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,404,576 shares of the real estate investment trust's stock valued at $26,139,000 after acquiring an additional 1,073,530 shares during the period. FMR LLC grew its holdings in shares of Sabra Health Care REIT by 89.7% during the third quarter. FMR LLC now owns 1,599,532 shares of the real estate investment trust's stock valued at $29,767,000 after purchasing an additional 756,418 shares during the last quarter. Finally, Principal Financial Group Inc. boosted its holdings in shares of Sabra Health Care REIT by 2.5% during the fourth quarter. Principal Financial Group Inc. now owns 22,109,683 shares of the real estate investment trust's stock valued at $382,940,000 after acquiring an additional 536,247 shares during the period. 99.40% of the stock is owned by institutional investors.

Remove Ads

Sabra Health Care REIT Stock Performance

SBRA traded up $0.11 on Wednesday, hitting $17.26. 1,935,644 shares of the stock traded hands, compared to its average volume of 1,981,263. The firm has a market capitalization of $4.11 billion, a PE ratio of 32.57, a P/E/G ratio of 1.97 and a beta of 1.27. The company has a current ratio of 4.32, a quick ratio of 4.16 and a debt-to-equity ratio of 0.88. Sabra Health Care REIT, Inc. has a 52 week low of $13.31 and a 52 week high of $20.03. The business has a fifty day moving average price of $16.81 and a two-hundred day moving average price of $17.68.

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last released its quarterly earnings data on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share for the quarter, meeting the consensus estimate of $0.36. The company had revenue of $182.35 million for the quarter, compared to analyst estimates of $178.01 million. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. On average, research analysts predict that Sabra Health Care REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Health Care REIT Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Friday, February 14th were given a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a yield of 6.95%. Sabra Health Care REIT's dividend payout ratio (DPR) is presently 226.42%.

Analyst Ratings Changes

A number of research firms have weighed in on SBRA. Truist Financial upped their target price on Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a "hold" rating in a research report on Tuesday, March 18th. Mizuho reaffirmed a "neutral" rating and set a $20.00 target price on shares of Sabra Health Care REIT in a research note on Thursday, December 5th. JMP Securities raised Sabra Health Care REIT from a "market perform" rating to an "outperform" rating and set a $20.00 target price on the stock in a report on Tuesday, January 7th. Finally, Citizens Jmp raised shares of Sabra Health Care REIT from a "hold" rating to a "strong-buy" rating in a report on Tuesday, January 7th. Three analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Sabra Health Care REIT has an average rating of "Moderate Buy" and a consensus target price of $19.33.

Sabra Health Care REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.